Brendan McCarty

“Appreciate you taking my questions here. Wanted to circle back to the Lima Sur asset sale. I know you mentioned it sold at about 18% above the recently appraised value.”

“Appreciate you taking my questions here. Just wanted to follow up on the regulatory environment of tokenization. McAndrew, I know you've cited the potential passing of the Clarity Act as maybe a key catalyst.”

“And then you're obviously really strong order intake in the quarter i think that's great to see uh but are did you have to make any pricing concessions there to win these orders or do you anticipate the same kind of mid teams gross margin profile um on the orders that are in the backlog at this point so i'll enter in…”

“Appreciate you taking my questions here. Just wanted to have a follow-up question on the guidance increase. It looks like you're taking up guidance 30 cents at the midpoint.”

“I just wanted to start off on the outlook here. Origination's down 11% year rear. That makes sense, considering your tighter underwriting position. How does the new risk-based pricing initiative fit into the 2026 guidance that calls for a mid-single-digits increase for the year?”